This session shares case studies of patients who received stem cell transplants and then developed acute kidney injury. The assessment necessary to note this development, the evaluation prior to stem cell transplant, along with the renal complications that followed are outlined. Lab values, interventions, and post-hospitalization care also are shared during this informative session.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 9/19/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no speaker disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: After completing this educational activity, the learner will be able to assess and recognize the risk for, and development of, acute kidney injury in patients who have had stem cell transplants.
MD, FACP, FASN, HP (ASCP),
Medical Director and Professor,
University of Virginia Health System